Patents by Inventor Esteban Fridman

Esteban Fridman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7943632
    Abstract: Methods and compositions are described for treating impaired neurological function, including altered state of consciousness disorders, in an individual who has sustained a brain injury comprising administering to the individual apomorphine. Methods and compositions are described for treating impaired neurological function, including altered state of consciousness disorders, in an individual who has sustained a brain injury comprising administering to the individual at least 1000 mg or more of L-dopa (levodopa) per day. The use of potent dopaminergic agents to stimulate emergence from an altered consciousness state, such as a coma, is disclosed.
    Type: Grant
    Filed: September 30, 2005
    Date of Patent: May 17, 2011
    Assignee: NeuroHealing Pharmaceuticals, Inc.
    Inventors: Daniel E. Katzman, Elkan R. Gamzu, Neal M. Farber, Esteban A. Fridman, Marcelo Merello
  • Publication number: 20070066996
    Abstract: The invention provides methods of treating an impaired neurological function associated with brain injury in an individual comprising administering to the individual an effective amount of modafinil. The use of modafinil, especially in conjunction with a neurorehabilitation program, is effective to improve or restore one or more neurological functions that were impaired due to brain injury in an individual.
    Type: Application
    Filed: March 17, 2004
    Publication date: March 22, 2007
    Inventors: Daniel Katzman, Elkan Gamzu, Neal Farber, Esteban Fridman
  • Publication number: 20060089373
    Abstract: Methods and compositions are described for treating impaired neurological function, including altered state of consciousness disorders, in an individual who has sustained a brain injury comprising administering to the individual apomorphine. Methods and compositions are described for treating impaired neurological function, including altered state of consciousness disorders, in an individual who has sustained a brain injury comprising administering to the individual at least 1000 mg or more of L-dopa (levodopa) per day. The use of potent dopaminergic agents to stimulate emergence from an altered consciousness state, such as a coma, is disclosed.
    Type: Application
    Filed: September 30, 2005
    Publication date: April 27, 2006
    Inventors: Daniel Katzman, Elkan Gamzu, Neal Farber, Esteban Fridman, Marcelo Merello